Spatial Genomics and Transcriptomics market to reach $1.9B by 2035 with 12.23% CAGR driven by AI and precision medicine.

The Spatial Genomics and Transcriptomics market, valued at $0.60 billion in 2025, is projected to grow to $1.90 billion by 2035 at a CAGR of 12.23%. Growth is fueled by increasing adoption of AI-powered spatial biology, precision medicine, and molecular profiling in oncology and translational research. North America leads the market, followed by Europe and Asia Pacific, with Asia Pacific showing the highest growth rate due to rising biotech investments. Key segments driving growth include consumables & reagents, spatial transcriptomics technology, and oncology research applications, with pharmaceutical and biotech companies as primary users.